← All trends
World Wellness Guide
National Trend
Women's hormonal health

PCOS market: 2.1M searches a month

3.9M
searches/mo for the #1 result on "pcos demand-driver map"
1Glp 13.9M/mo, +10% 6mo3.9M2Tirzepatide3.2M/mo, +28% 6mo3.2M3Semaglutide2.1M/mo2.1M4Berberine2.1M/mo, +31% 6mo2.1M5Continuous Glucose Monitor1M/mo, +6% 6mo1M6Medical Weight Loss973K/mo, +29% 6mo973K
Confidence: StrongAs of 2026-07-10

global · market pattern

PCOS market: 2.1M searches a month

About 2.1M people a month search PCOS across 30 tracked markets. The products this group turns to are led by Glp 1, Tirzepatide, Semaglutide.

What the PCOS economy actually looks like, sized by real search demand and the products people turn to.

What it isthe hormonal condition affecting roughly 1 in 10 women of reproductive age

Working hypothesisAI-suggested

PCOS searchers increasingly land on metabolic tools, berberine and GLP-1 drugs, treating it as an insulin-resistance problem rather than only a fertility one.

The evidence

condition demand
2.1M searches a month for PCOS itself, summed across 30 tracked markets (2026-06) [MEASURED]
top linked demand
Glp 1: 3.9M searches a month [MEASURED]
map
7 products mapped to PCOS in the demand-driver map [MEASURED edges, INFERRED that this population searches and buys them]
note
Headline is search demand for the condition term itself, a clean measured number. Linked products are ranked by their own global demand; they overlap across conditions (a GLP-1 search is not only a PCOS search), so they are shown as a leaderboard, not summed into a single market size. Money and sales are not measured.

The full ranking

6 tracked · pcos demand-driver map.

  1. 1Glp 13.9M/mo, +10% 6mo
  2. 2Tirzepatide3.2M/mo, +28% 6mo
  3. 3Semaglutide2.1M/mo
  4. 4Berberine2.1M/mo, +31% 6mo
  5. 5Continuous Glucose Monitor1M/mo, +6% 6mo
  6. 6Medical Weight Loss973K/mo, +29% 6mo